A phase II study with tegafur/uracil and peg-interferon after TACE [trans-arterial chemoembolisation] for hepatocellular carcinoma
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Peginterferon (Primary) ; Tegafur/uracil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 12 May 2016 Status changed from recruiting to discontinued.
- 05 Nov 2007 New trial record.